Abstract Body

Currently, there is no curative treatment for hepatitis B virus (HBV) infection. Available antivirals control replication and mitigate inflammation but -as in HIV infection- cannot attack the nuclear persistence form of the virus. Virus-specific immunity can eliminate and control HBV, but antibody, as well as T-cell responses, are barely detectable in chronic infection. Activating HBV-specific immunity may therefore be the clue to achieve HBV cure.